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Objectives: To address increasing rates of stimulant misuse in college students, this study 
developed an evidence-based, brief clinical practice intervention for primary care providers 
(PCPs) to reduce stimulant medication diversion among young adults with ADHD. Methods: 
College students (N-114; 18-25 years; 68% attending universities; 24% attending community 
college) treated for ADHD with a stimulant and their PCPs across six practices participated in 
this initial, uncontrolled study of pre- to post-intervention change. An educational workshop 
providing strategies aimed at reducing stimulant diversion was developed and delivered to 
providers and staff across all practices (50% pediatric; 50% family medicine). Patients and 
providers completed baseline and post intervention surveys. Results: Diversion was relatively 
infrequent, 16.7% at baseline and 14.9% post-intervention, respectively. Statistically significant 
decreases from baseline to post-intervention were found for three diversion risk factors: (1) 
number of times approached to divert, (2) intent to share, sell, or trade stimulants, and (3) 
disclosure of stimulant use. Providers and staff reported mostly high satisfaction with the 
training. Conclusions: This study provides initial evidence for a PCP-delivered intervention to 
reduce stimulant diversion. Research is needed on the efficacy of targeting college students 







Stimulant medications for Attention-Deficit/Hyperactivity Disorder (ADHD), 
amphetamines and methylphenidate, are among the most researched and acutely efficacious 
psychoactive medication treatments in behavioral health.1,2  They are also classified by the U.S. 
Food and Drug Administration as Schedule II controlled substances due to their potential for 
abuse.  Although few children and adults with ADHD misuse their prescribed stimulants (i.e., 
take more than prescribed),3,4 non-prescribed use by college students is prevalent.  In one of the 
largest surveys to date, 9.3% of undergraduates used them without a prescription in the prior 
year, and prevalence increased significantly between 2003 and 2013.5  Between 2005 and 2010, 
stimulant-related presentations to the emergency department increased by 68%.6  As a result, 
calls have been made at the national level for the development of preventive methods.6-8   
Surveys have revealed that non-prescribed stimulants are largely acquired from peers who 
share, sell, or trade their own prescribed medication8,9 to other students to enhance academic 
performance or for recreation.9-11  One-quarter to one-third of college students prescribed 
stimulants report diverting their medication, and well over half are approached to divert.12-14  A 
small cross-sectional literature suggests some similarity between diverters and misusers in risk 
characteristics such as having friends who misuse stimulants, recreational substance use (e.g., 
marijuana), and other externalizing behaviors.15-18  In addition to the obvious legal risks of 
distributing a controlled substance, diversion increases risk of untreated ADHD.  Reducing 
diversion is therefore important for individuals with prescriptions, and it has the potential to 
lower the rate of non-prescribed stimulant misuse among college students.   
Intervening at the level of the prescribing provider is a potential route to stimulant diversion 
reduction.  Past studies have demonstrated reduction in risk behaviors, such as alcohol misuse, 
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after brief intervention in primary care.19-21  However, current practice guidelines for treating 
ADHD do not offer specific strategies for addressing diversion.22  Moreover, most stimulant 
prescriptions are written in primary care settings and primary care providers (PCPs) are often the 
sole managers of care for children with ADHD up to at least age 21.23  Thus, there is a need to 
develop and test evidence-based strategies for reducing diversion risk in primary care. The 
current study reflects the first systematic attempt to develop a training workshop for PCPs and 
their staff on brief clinical practice strategies for the prevention of stimulant diversion by their 
college student patients with ADHD. In a pre-post design, we hypothesized that after provider 
and staff training, patients would report reduced stimulant diversion and associated risk for the 
sharing, selling, and trading of prescribed stimulant medications for ADHD.  
Methods 
Overview 
Patients, n=114, from six primary care practices (3 pediatric, 3 family medicine) participated 
in a study of stimulant diversion risk following provider and practice staff training in stimulant 
diversion prevention.  Surveys were collected from patients twice – pre- (Time 1) and post- 
(Time 2) training -- and their reports of stimulant diversion risk are the focus of this paper.  
Satisfaction ratings were collected from providers and practice staff immediately after training.   
Participating practices and patients 
Primary care practices.  Practices were selected based on geographic proximity (within 
~20 miles of the University of Pittsburgh), participation in Pediatric PittNet (a practice-based 
research network hosted by the university; pediatric practices only), practice size (targeting 
larger practices), and provider willingness; no practices declined participation.  Practices were 
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predominantly suburban (one pediatric practice was within the city of Pittsburgh). (See 
Supplement 1 for data describing practices.) 
Patients.  Patients were recruited if they were 18-25 years old and prescribed stimulant 
medication for ADHD (any diagnostic or billing code related to ADHD) at one of the six 
participating practices.  Patients were required to be in post-secondary education or training. 
Table 1 provides additional descriptive information on enrolled patients.  Figure 1 describes the 
method and flow of recruitment.   
Data Collection 
 Patients completed electronic surveys, programmed in Qualtrics (Provo, UT), about 
stimulant diversion and associated risk behaviors at Time 1 and Time 2.  Time 2 assessments 
occurred M(SD)=7.26 (1.70) months after provider and practice staff stimulant diversion 
prevention training.  Patients were assured confidentiality, including from their providers, 
bolstered by a NIDA-issued Certificate of Confidentiality. Informed consent was collected from 
all participating providers, staff, and patients; the study was IRB-approved. 
Measures.  In addition to basic demographics and stimulant diversion, domains of 
assessment reflected psychosocial and environmental factors related to diversion and misuse.12,15-
18,24,25  Surveys were pilot-tested by research staff and five patients at an ADHD specialty clinic 
at Western Psychiatric Hospital, Pittsburgh, PA.  Electronic medical records (EMRs) were 
reviewed for patient contact with their study practice between provider training and completion 
of the Time 2 survey. 
Stimulant diversion was assessed with questions about selling, sharing, or trading 
prescribed stimulant medication (e.g., “How many times in the last year has someone asked you 
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to share your stimulant medication for studying?”, “Did you actually share your stimulant 
medication for studying?”, 0=no, 1=yes).  Items assessed self- and other-initiated diversion (e.g., 
“How many times in the last year have you offered your medication to a friend—to help them 
study—without their asking?”).  Diversion for recreational purposes (“…for partying”) was also 
assessed.  To accommodate skew, diversion was coded “1” (else=0) if any selling, sharing, or 
trading occurred in the last year.  Approached to divert in the last year was a count of the 
number of times patients were approached to share for studying, for partying, or to buy (3 items, 
open-ended response).  Intent to divert was modeled after similar measures used with 
adolescents.26  Patients were asked how likely they were to give away, sell, or trade their 
stimulant medication in each of 9 situations such as “to help a friend or family member who 
needed it to study.”  Response options ranged from 0=not at all likely to 3=very likely.  The 
variable analyzed was a count of situations that the patient indicated any likelihood of diverting 
(score of 1 or higher).  Perceived harm to self was one item indexing “likelihood that you 
would get in trouble for giving away, selling, or trading your stimulant medication?”; four 
responses ranged from 1=0-25% chance to 4=76-100% chance.  Perceived harm to others, 
mean score (3 items), was adapted from Johnston and colleagues27 to assess how much people 
risk harming themselves, physically or in other ways, if they take stimulant medication without a 
prescription once or twice, occasionally, or regularly, alpha(T1)=0.82.  Responses were 0=no 
risk to 3=great risk.  Knowledge of school policies was one item inquiring about awareness 
(0=no; 1=yes) of their school policies about stimulant medication.  Stimulant use disclosure 
was number of social network types (e.g., roommates, a small circle of friends, coworkers, 
acquaintances) who know that the patient has a stimulant prescription (family members and 
romantic partners were excluded).  Stimulant storage (access) was one item, “Is your stimulant 
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medication kept in a shared location where other people have access to it?” (0=no, 1=yes).  
Changed storage was one item at Time 2 only, “In the last year, have you changed how you 
store your stimulant medication?” (0=no, 1=yes), followed by an open-ended query, “What did 
you change and why?” Stimulant storage (locked) was one item, “Do you typically lock up 
your stimulant medication?” (0=no, 1=yes).  Patients also reported any psychoactive medication 
use.                
Intervention (Stimulant Diversion Prevention Training) 
 All providers and practice staff interfacing with patients (e.g., nurses, medical assistants, 
receptionists) were asked to attend a one-hour workshop on brief clinical practice strategies to 
reduce the likelihood of stimulant diversion by their patients (a total of 55 providers and 75 
additional staff attended).  Workshops were conducted at each practice and led by the first author 
(BSGM) and clinical coordinator (HLK).  Continuing medical education credit and meals were 
provided.  A prescribing provider of record for all but six patients participated in training.  Two 
to eight providers at each practice had one to 14 patients in the study, M(SD)=3.60 (3.16) 
patients/provider. 
 The workshop content included training in 1) brief patient education and counseling (e.g., 
negative consequences of diversion), 2) enhancing diversion prevention strategies, and 3) 
effective medication monitoring.   The presentation included three brief video demonstrations of 
provider:patient interactions.  A handout was provided in ample quantity, and with 
demonstration of its use, to facilitate provider:patient discussion. Workshop content was based 
on selected findings from the Time 1 surveys, consultations with providers, methods for opioid 
management,28,29 recent recommendations for provider behavior when prescribing stimulants,7,8 
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and trials in pediatric care to reduce adolescent health risk behaviors.30  The workshop was 
refined with consultant feedback and piloting in the ADHD clinic. 
Statistical Analysis 
Generalized Estimating Equations (GEE) analyses were used to analyze data for all 
available patients and to account for the correlated nature of the repeated measurements within 
each patient.  Several types of GEE models were used for a priori outcome variables: binomial 
logistic for binary outcomes, negative binomial with log link for count outcomes, linear models 
for continuous (interval scale; mean score) outcomes, and multinomial distribution with 
cumulative logit link for ordinal outcomes. Practice effects were accounted for through a fixed-
effects approach (practice was treated as a nominal covariate).  Preliminary analyses showed 
dependence among patients sharing a provider to be negligible (working correlations across 
outcomes were uniformly small, -.01-.02).  Provider effects were therefore not included in the 
fitted models.   
Results 
Participation and treatment by Time 2 
 At Time 2, 93% (106/114) participated (M=14.1 months after Time 1, SD=4.4, mean 
age=21.5, SD=1.6).  Most (82.1%, 87/106) were enrolled in post-secondary education in the past 
year:  64.4% (56/87) in a 4-year college/university; 19.5% (17/87) in community college or trade 
school; 9% (8/87) in advanced college education; 3.4% (3/87) in on-the-job training.  Nearly all 
(95.2%, 100/105) were still taking a prescription stimulant.  (Medication information was 
missing for one patient at Time 2.)  Most (76.4%; 81/106) were still receiving treatment at their 
Time 1 practice.  Of those for whom identifiable EMR data were available to the study team 
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(n=97) and were still medicated (n=75), 75% (n=56/75) had EMR-recorded contact related to 
ADHD treatment with their provider’s office after diversion prevention training (e.g., office visit, 
prescription, phone conversation), M(SD)=3.40(3.66) contacts, range=1-17.  Slightly more had 
contact with their practice for any reason, 83% (62/75).  
Diversion and risk factors, Time 1 to Time 2 
 Table 2 shows the results of the analyses examining change in diversion and diversion risk 
from Time 1 to Time 2.  None of the practice effects were statistically significant at p<.05. 
 Diversion was infrequent, with 16.7% and 14.9% diverting at Times 1 and 2, respectively.  
This reduction was not statistically significant.  For descriptive purposes, we provide the 
breakdown of diversion behaviors at Time 1:  75.0% (12/16) diverted for cognitive performance 
(studying), and 18.8% (3/16) diverted for recreational purposes (partying). One person diverted 
for studying and for partying.  For n=3, reasons for diverting were not available.  The mean 
number of times diverting was 1.79(SD=1.27), range=1-6, n=19. 
 Statistically significant reduction was found for three of eight diversion risk factors 
(approached to divert, intent to divert, and stimulant use disclosure). The average number of 
times approached to divert was reduced by half, from 10.5 to 4.5 times in the last year.  At Time 
1, 52.6% (60/114) were approached to divert (range=1 to 106 times).  Of those, 36.7% (22/60) 
were approached for studying, 5.0% (3/60) were approached for partying, and 50.0% (30/60) 
were approached for both reasons (8.3% or 5/60 were approached to sell without associated 
reason). At Time 2, 33.9% (36/106) were approached to divert (range=1 to 112 times). Of those, 
41.7% (15/36) were approached for studying, 11.1% (4/36) were approached for partying, and 
47.2% (17/36) were approached for both reasons. 
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 Intent to divert decreased significantly over time.  The mean number of situations in which a 
patient would divert dropped to 0.89 from 1.20. Although most endorsed being “not at all likely” 
to divert across all situations, intent was more likely in situations involving a friend or family 
member needing the medication for reasons other than recreational use.  Figure 2 displays these 
results by situation at Times 1 and 2.  At Time 2, the circumstances that produced the greatest 
reported likelihood of diversion were to friends or family for studying (22%, down from 27% at 
Time 1) or to replenish an existing prescription (25%, down from 33% at Time 1).  Very few 
patients (1%-6%) reported any likelihood, pre- or post-training, of diverting their medication to 
acquaintances or strangers for any reason.   
 The number of non-family, non-romantic partner social network types who knew about the 
patients’ stimulant medication decreased significantly, from mean of 2.77 to 1.99.  Table 2 
shows that the number of roommates, friends, and coworkers or acquaintances who knew were 
significantly lower at Time 2, and the odds of these social network types knowing about the 
patient’s stimulant medication usage were halved by Time 2.  
 No other diversion risk factors changed significantly.  Most patients reported 0-25% chance 
of getting in trouble for diverting their stimulant medication (perceived harm to self).  Perceived 
harm to others was very stable and perceived as greatest for regular use of stimulants without a 
prescription.  For example, at Time 1, 79.8% (91/114) of patients perceived “moderate risk” 
(response=3) or “great risk” (response=4) for individuals taking stimulants without a prescription 
“regularly” versus 21.9% (25/114) perceiving moderate or great risk associated with taking 
stimulants without a prescription “once or twice.”  Knowledge of school policies pertaining to 
stimulant misuse was low.  For stimulant storage, a substantial minority reported keeping their 
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medications in locations accessible to others (under 30% at both times), and few (12% at both 
times) reported locked storage of their stimulant medication. 
 At Time 2, 21% (22/105) reported having changed how they store their medication.  Post-
hoc exploration of reported storage locations revealed an increase from Time 1 to Time 2 in 
purse/backpack storage (see Supplement 2).  
Satisfaction and feasibility 
 Table 3 shows that provider and staff ratings of satisfaction collected immediately following 
training were generally high. Providers and staff indicated a “moderate” perceived need for 
additional training to feel comfortable using the diversion risk skills and strategies.  
Discussion 
 This study provides new data pertinent to the prevention of stimulant misuse by college 
students being treated for ADHD.  Brief clinical practice strategies for use in primary care, to 
aide in the prevention of stimulant medication diversion by college student patients, were 
developed and delivered in educational workshops to primary care providers and their practice 
staff in an open, uncontrolled clinical trial.  Patients treated across primary care practices 
reported low rates of stimulant diversion, but patient diversion risk decreased after training.  An 
absence of practice effects suggests that results generalize to pediatric and family medicine 
settings.  These findings provide preliminary evidence for the ability of pediatric and family 
medicine PCPs to lower stimulant diversion risk and thereby decrease the supply of medicine 
that supports non-prescribed stimulant use by college students. 
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 Less than 20% of patients reported diverting their stimulants.  This low base rate made post-
intervention change difficult to detect and interesting relative to higher rates reported 
elsewhere.8-10,12,13,31  Population sampling differences may be contributing.  Wilens and 
colleagues found that only 11% of their still stimulant-medicated participants followed from 
childhood were selling their medication.32  Individuals with long histories of treatment and 
strong relationships with providers may be less likely to divert.  In contrast to existing surveys of 
college students, about a quarter of our patients were in community college which may lower 
diversion risk (e.g., little time spent on campus outside of classes33).  Diversion of stimulant 
medication did not increase over time, suggesting that patient/provider discussions about the 
problem of stimulant misuse and diversion did not have iatrogenic effects. 
The diversion prevention training presented our Time 1 finding that many patients were 
approached to divert.  Other studies have reported this9,13,34,35 which makes the possibility of this 
social vulnerability especially important as a diversion risk factor.  After PCP training, the 
number of times that patients were approached was cut in half, from an average of 10.57 to 4.47 
times.  The variability of this important outcome was also reduced; fewer patients were 
approached 4 or more times (38.6% pre, and 23.8% post).  Being approached to divert has been a 
key factor in the literature on stimulant misuse because most college students who misuse 
stimulants obtain them from a peer with a prescription.8,9  Our PCP training emphasized 
vulnerability to approach based on their patients’ baseline data (aggregated across sites), making 
the data directly applicable.  We also shared the well-documented tendency for individuals with 
ADHD to have interpersonal difficulties which may increase diversion vulnerability.36-38  If our 
rates of actual diversion are under-estimates, which is possible when measuring any socially 
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undesirable behavior, then the reduction in approaches to divert is especially promising as a 
prevention target. 
 We found a reduction in the number of social network types who knew about the patients’ 
stimulant prescriptions.  The findings are encouraging, although we can only infer that this 
change is in response to reduced patient disclosure.  In the PCP training, providers were coached 
to encourage their patients to disclose information about their treatment selectively.  Our findings 
suggest that a fairly simple conversation, delivered briefly yet effectively (we encouraged and 
demonstrated motivational enhancement-style interactions39,40), may have important effects on 
patient behavior.   
 Behavioral intentions have repeatedly been shown to be the strongest proximal predictor of 
adolescent health risk behavior.41,42  We found a statistically significant reduction in intentions to 
divert stimulant medication which signified, despite low rates of diversion, room for 
improvement in a salient risk factor.  When we examined the individual items assessing 
intentions, decreased likelihood of diverting to friends or family members was primarily 
responsible for the change. 
 Although modest, these pre-post changes in diversion risk are promising.  Future tests of 
mediating variables, such as patient-reported change in provider behavior, may be illuminating 
and increase confidence in our training as a method of diversion prevention.  We are unable to 
know with certainty the extent to which providers and additional practice staff adopted the 
strategies, because direct observations were impractical (strategy implementation was expected 
across providers and practice staff, across different kinds of interactions).  Our finding that 75% 
of the patients had ADHD-related contact with their practice between workshop delivery and 
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Time 2 hints at the possibility that diversion risk might have improved more with greater contact. 
Importantly, the uncontrolled nature of our pre-post study design leaves open the possibility that 
other, unmeasured, factors may account for the reduction in diversion risk.  For example, 
increased media reports of the dangers of stimulant misuse, although not changing perceived 
harm per se, may have been responsible for changing intentions.  Cognitive maturation typical of 
this age43,44 that may occur for some with ADHD alongside decreasing symptoms of ADHD45 
may also underlie our pre-post changes. A randomized controlled trial is necessary to more 
definitely conclude that the training was responsible for the reduction in diversion risk. 
 The remaining diversion risk variables did not change.  At Time 2, about one-quarter 
(26.3%) reported a greater than 50% chance of getting in trouble if they were caught diverting.  
Our intervention did not specifically address this perception but rather emphasized the range of 
negative consequences that might follow from diversion (including those associated with being 
caught).  It is somewhat surprising that perceived harm did not increase given the changes we 
observed in approaches and intent to divert.  This may be due to patients already having 
reasonable expectations of risk.  For example, knowledge of school policies stayed low, but our 
own online research of local colleges and universities suggested lack of policies specifically 
related to stimulants.  Patients may also perceive little reason to investigate this information in 
the absence of diversion.  Regarding secure storage of medication, most patients stored their 
medication in non-shared locations but not under lock and key.  We speculate that preference for 
easy access to medication often taken at times of greatest need (e.g., while attending class or 
completing homework) may take precedence; the post-hoc finding that purse/backpack storage 
increased by Time 2 aligns with this notion. 
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 Our provider and staff training session was very brief yet ratings of satisfaction, relevance, 
and feasibility were generally high.  About one-third of providers and staff indicated a need for 
additional training; planned analyses of provider-reported strategy implementation and 
associated factors such as skill self-efficacy and perceived knowledge about ADHD medication 
prescribing should pinpoint areas for additional training in the future.  Other ratings were high, 
and characteristics of our training preparation and delivery may have contributed (e.g., 
incorporating feedback from consultants including PCPs, using study data to increase relevance, 
on-site training with continuing education and meals). The generally high ratings should aide 
dissemination in the future.46 
Conclusions 
The findings of this study are encouraging and suggest that a brief PCP training package is 
feasible, well-received by providers and staff, and may lead to reduced stimulant diversion risk 
among college students.  Importantly, our findings also suggest the absence of iatrogenic effects 
(e.g., increased diversion).   Finally, our results revealed no practice effects which suggests that 
these strategies may be effective in pediatric and family medicine settings. The pre-post design 
of this study without a comparison group makes it difficult to know whether the findings reflect 
natural trends over time for college students versus the effects of our training program.  A 
randomized controlled trial is needed to address this question. It is also helpful to recognize the 
developmental nature of the assessment battery and limited racial and ethnicity diversity of the 
sample.  The training to reduce diversion risk described herein reflects only one facet of a multi-
pronged approach needed to reduce stimulant misuse.  In addition to equipping providers and 
their staff with knowledge and skills, research is needed on the efficacy of targeting college 
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students directly, working with dispensing pharmacies and student health centers, and targeting 





1. Fredriksen M, Halmøy A, Faraone SV, Haavik J. Long-term efficacy and safety of treatment with 
stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies. Eur 
Neuropsychopharmacol. 2013;23(6):508-527. 
2. Faraone SV, Buitelaar J. Comparing the efficacy of stimulants for ADHD in children and 
adolescents using meta-analysis. Eur Child Adolesc Psychiatry. 2010;19(4):353-364. 
3. Molina BSG, Howard AL, Swanson JM, et al. Substance use through adolescence into early 
adulthood after childhood-diagnosed ADHD: findings from the MTA longitudinal study. Journal 
of child psychology and psychiatry, and allied disciplines. 2018;59(6):692-702. 
4. Wilens TE, Adler LA, Adams J, et al. Misuse and diversion of stimulants prescribed for ADHD: a 
systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47(1):21-31. 
5. McCabe SE, West BT, Teter CJ, Boyd CJ. Trends in medical use, diversion, and nonmedical use of 
prescription medications among college students from 2003 to 2013: Connecting the dots. 
Addict Behav. 2014;39(7):1176-1182. 
6. Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 
2011:  National Estimates of Drug-Related Emergency Department Visits. In: HHS Publication No. 
(SMA) 13-4760, ed. Rockville, MD2013. 
7. Arria AM, DuPont RL. Nonmedical prescription stimulant use among college students: why we 
need to do something and what we need to do. J Addict Dis. 2010;29(4):417-426. 
8. DeSantis AD, Anthony KE, Cohen EL. Illegal college ADHD stimulant distributors: Characteristics 
and potential areas of intervention. Subst Use Misuse. 2013;48(6):446-456. 
9. Gallucci AR, Martin RJ, Usdan SL. The diversion of stimulant medications among a convenience 
sample of college students with current prescriptions. Psychol Addict Behav. 2015;29(1):154. 
10. Rabiner DL. Stimulant prescription cautions: addressing misuse, diversion and malingering. Curr 
Psychiatry Rep. 2013;15(7):375. 
11. Clemow DB, Walker DJ. The potential for misuse and abuse of medications in ADHD: a review. 
Postgraduate medicine. 2014;126(5):64-81. 
12. Sepulveda DR, Thomas LM, McCabe SE, Cranford JA, Boyd CJ, Teter CJ. Misuse of prescribed 
stimulant medication for ADHD and associated patterns of substance use: preliminary analysis 
among college students. Journal of pharmacy practice. 2011;24(6):551-560. 
13. Rabiner DL, Anastopoulos AD, Costello EJ, Hoyle RH, McCabe SE, Swartzwelder HS. The misuse 
and diversion of prescribed ADHD medications by college students. J Atten Disord. 
2009;13(2):144-153. 
14. Gallucci AR, Martin RJ, Usdan SL. The diversion of stimulant medications among a convenience 
sample of college students with current prescriptions. Psychology of Addictive Behaviors. 
2015;29(1):154-161. 
15. DeSantis AD, Anthony KE, Cohen EL. Illegal college ADHD stimulant distributors: characteristics 
and potential areas of intervention. Subst Use Misuse. 2013;48(6):446-456. 
16. Wilens MDT, Gignac M, Swezey A, Monuteaux M, Biederman J. Characteristics of adolescents 
and young adults with ADHD who divert or misuse their prescribed medications. Journal of the 
American Academy of Child & Adolescent Psychiatry. 2006;45(4):408-414. 
17. Lasopa SO, Striley CW, Cottler LB. Diversion of prescription stimulant drugs among 10-18-year-
olds. Current opinion in psychiatry. 2015;28(4):292-298. 
18. McCabe SE, West BT, Teter CJ, Ross-Durow P, Young A, Boyd CJ. Characteristics associated with 




19. Kaner EF, Beyer FR, Muirhead C, et al. Effectiveness of brief alcohol interventions in primary care 
populations. The Cochrane database of systematic reviews. 2018;2:Cd004148. 
20. Ozer EM, Adams SH, Orrell-Valente JK, et al. Does delivering preventive services in primary care 
reduce adolescent risky behavior? The Journal of adolescent health : official publication of the 
Society for Adolescent Medicine. 2011;49(5):476-482. 
21. Kalu N, Cain G, McLaurin-Jones T, et al. Impact of a multicomponent screening, brief 
intervention, and referral to treatment (SBIRT) training curriculum on a medical residency 
program. Subst Abus. 2016;37(1):242-247. 
22. Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with 
attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894-
921. 
23. Anderson LE, Chen ML, Perrin JM, Van Cleave J. Outpatient visits and medication prescribing for 
US children with mental health conditions. Pediatrics. 2015;136(5):e1178-e1185. 
24. Benson K, Flory K, Humphreys KL, Lee SS. Misuse of Stimulant Medication Among College 
Students: A Comprehensive Review and Meta-analysis. Clinical Child and Family Psychology 
Review. 2015;18(1):50-76. 
25. Jardin B, Looby A, Earleywine M. Characteristics of college students with attention-deficit 
hyperactivity disorder symptoms who misuse their medications. Journal of American college 
health : J of ACH. 2011;59(5):373-377. 
26. Choukas-Bradley S, Giletta M, Cohen GL, Prinstein MJ. Peer influence, peer status, and prosocial 
behavior:  An experimental investigation of peer socialization of adolescents' intentions to 
volunteer. Journal of Youth & Adolescence. 2015;44:2197-2210. 
27. Johnston LD OMP, Bachman JG, Schulenberg, JE, . Monitoring the Future national results on 
adolescent drug use: Overview of key findings, 2012. Ann Arbor: Institute for Social Research, 
University of Michigan; 2013. 
28. Wiedemer NL, Harden PS, Arndt IO, Gallagher RM. The opioid renewal clinic: a primary care, 
managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain 
medicine. 2007;8(7):573-584. 
29. Chou R, Fanciullo GJ, Fine PG, et al. Clinical Guidelines for the Use of Chronic Opioid Therapy in 
Chronic Noncancer Pain. The Journal of Pain. 2009;10(2):113-130.e122. 
30. Ozer EM, Adams SH, Lustig JL, et al. Increasing the screening and counseling of adolescents for 
risky health behaviors: a primary care intervention. Pediatrics. 2005;115(4):960-968. 
31. Garnier LM, Arria AM, Caldeira KM, Vincent KB, O'Grady KE, Wish ED. Sharing and selling of 
prescription medications in a college student sample. Journal of Clinical Psychiatry. 
2010;71(3):262-269. 
32. Wilens TE, Gignac M, Swezey A, Monutaux MC, Biederman J. Characteristics of Adolescents and 
Young Adults With ADHD Who Divert or Misuse Their Prescribed Medications. Journal of the 
American Academy of Child & Adolescent Psychiatry. 2006;45(4):408-414. 
33. Ryan BE. Alcohol and Other Drugs: Prevention Challenges at Community Colleges. In. Newton, 
MA: The Higher Education Center for Alcohol and Other Drug Prevention; 1998. 
34. Schultz NR, Silvestri MM, Correia CJ. Diversion of prescription stimulants among college 
students: An initial investigation of injunctive norms. Addict Behav. 2017;65:264-268. 
35. McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use, and diversion of abusable prescription 
drugs. J Am Coll Health. 2006;54(5):269-278. 
36. Shaw-Zirt B, Popali-Lehane L, Chaplin W, Bergman A. Adjustment, social skills, and self-esteem in 
college students with symptoms of ADHD. Journal of Attention Disorders. 2005;8(3):109-120. 




38. Bagwell CL, Molina BS, Pelham WE, Hoza B. Attention-deficit hyperactivity disorder and 
problems in peer relations: Predictions from childhood to adolescence. J Am Acad Child Adolesc 
Psychiatry. 2001;40(11):1285-1292. 
39. Arkowitz H, Miller WR, Rollnick S. Motivational interviewing in the treatment of psychological 
problems. Guilford Publications; 2015. 
40. Rollnick S, Miller WR, Butler CC, Aloia MS. Motivational interviewing in health care: helping 
patients change behavior. In: Taylor & Francis; 2008. 
41. Malmberg M, Kleinjan M, Vermulst AA, et al. Do substance use risk personality dimensions 
predict the onset of substance use in early adolescence? A variable-and person-centered 
approach. J Youth Adolesc. 2012;41(11):1512-1525. 
42. Stephens PC, Sloboda Z, Stephens RC, et al. Universal school-based substance abuse prevention 
programs: Modeling targeted mediators and outcomes for adolescent cigarette, alcohol and 
marijuana use. Drug Alcohol Depend. 2009;102(1):19-29. 
43. Jernigan TL, Brown TT, Bartsch H, Dale AM. Toward an integrative science of the developing 
human mind and brain: Focus on the developing cortex. Developmental cognitive neuroscience. 
2016;18:2-11. 
44. Blakemore S-J, Choudhury S. Development of the adolescent brain: implications for executive 
function and social cognition. Journal of Child Psychology and Psychiatry. 2006;47(3-4):296-312. 
45. Sudre G, Szekely E, Sharp W, Kasparek S, Shaw P. Multimodal mapping of the brain's functional 
connectivity and the adult outcome of attention deficit hyperactivity disorder. Proceedings of 
the National Academy of Sciences of the United States of America. 2017;114(44):11787-11792. 
46. Wandersman A, Duffy J, Flaspohler P, et al. Bridging the gap between prevention research and 
practice: The interactive systems framework for dissemination and implementation. Am J 




-Patient at a participating practice
-18-25 years old
-Currently treated with stimulant medication for ADHD (all ADHD-related diagnostic codes)
N = 579*
Patients Screened by Phone
-Confirmed EMR inclusion criteria









1: N = 18
2: N = 17
3: N = 21
Family Medicine
1: N = 11
2: N = 36
3: N = 11
Excluded
N = 30






Not enrolled in post-secondary 
education
N = 16
No longer in age range
N = 6





Figure 1. Flow of Study Recruitment
Note: EMR-identified patients were initially contacted by practice staff during office visits, by letter, and/or by 
phone.  If the patient was successfully contacted and agreeable to participation, he/she was referred to study staff 
who completed phone screens to determine final eligibility.
*The number of EMR-identified patients by practice include the following:  n=74, 85, and 50 for pediatric practices 1, 
2, and 3, respectively (practice 3 is an estimate); n=51, 125, 194 for family medicine practices 1, 2, and 3, respectively.
No longer taking stimulants
N = 3
Figure 2. Likelihood of Diversion in Specific Situations by Time 
 
Note: T1 = Time 1 survey, n = 114; T2 = Time 2 survey, n = 105. Responses were rated on a 4-point scale ranging from 0 = Not at all likely to 3 = 
Very likely; 0 = Not at all likely not shown in figure for clarity.  Although analyzed as a count of situations that the participant indicated any 
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Table 1. Patient characteristics at Time 1 (n=114)
N %




White or Caucasian 109 (95.6%)
Native Hawaiian or Other Pacific Islander 1 (0.9%)
More than one race 4 (3.5%)
Hispanic Ethnicity 5 (4.4%)
Highest level of Parent Education 
High School Graduate 8 (7.0%)
Technical or specialized training 6 (5.3%)
Partial College 9 (7.9%)
Associate degree 7 (6.1%)
College graduate 44 (38.6%)
Graduate Degree 40 (35.1%)
Educational Type 
On the job training 4 (3.5%)
Community College or Trade School 27 (23.7%)
4-year college/university 77 (68.1%)






Full Time Student 93 (81.6%)
Fraternity/Sorority Member 23 (20.2%)
Housing Type
With parents 44 (38.6%)
On Campus 33 (28.9%)
Off Campus 23 (20.2%)
Fraternity/Sorority House 4 (3.5%)
Other 10 (8.8%)
Table 2. Change from Time 1 to Time 2 in diversion and diversion risk 
Time 1a Time 2b Results of GEE Models
n or 𝑥 % or SD n or 𝑥 % or SD Wald 2 p β SE Exp(β)
Diversion
Diverted in the last year, n (%) 19 (16.67) 17 (14.91) 0.003 (0.959) -0.01 (0.28) 0.99
Approached to Divert
Number of times approached in the last year, 
mean (SD)
10.51 (20.79) 4.47 (12.72) 17.548 (0.000) -0.94 (0.22) 0.39
Intent to Divert
Intent to divert, mean (SD) 1.20 (1.84) 0.89 (1.79) 4.666 (0.031) -0.03 (0.01) 0.97
Perceived Harm of Diversion 
To self (likelihood of getting in trouble), n (%) 0.119 (0.730) -0.07 (0.20) 0.93
0-25% 68 (59.65) 59 (51.75)
26-50% 8 (7.02) 16 (14.04)
51-75% 10 (8.77) 10 (8.77)
76-100% 26 (22.81) 20 (17.54)
  To others, mean (SD) 1.57 (0.73) 1.55 (0.86) 0.157 (0.692) -0.04 (0.09) -
Knowledge 
Knowledge of school policies (for stimulant 
medication), n (% with reported awareness)
26 (22.81) 27 (23.68) 0.833 (0.361) 0.22 (0.24) 1.25
Stimulant Use Disclosure
Number of social network types who know about 
your stimulant medication, mean (SD) 
2.77 (2.17) 1.99 (1.96) 15.922 (0.000) -0.44 (0.11) 0.64
How many roommates know 0.89 (0.87) 0.66 (0.86) 7.038 (0.008) -0.55 (0.21) 0.58
How many friends know 1.04 (0.76) 0.74 (0.75) 15.411 (0.000) -0.79 (0.20) 0.45
How many fraternity brothers/sorority sisters 
know
15 (13.16) 15 (13.16) 0.919 (0.338) -0.53 (0.56) 0.59
How many coworkers or acquaintances know 0.20 (0.50) 0.10 (0.39) 3.861 (0.049) -0.85 (0.43) 0.43
Stimulant Storage
Access (shared location), n (%) 31 (27.19) 26 (22.81) 0.282 (0.595) -0.13 (0.25) 0.88
Locked storage, n (%) 14 (12.28) 14 (12.28) 0.048 (0.827) 0.08 (0.36) 1.08
Note: aTime 1: n = 114, bTime 2: n = 105.
Table 3. Provider and staff satisfaction at the conclusion of the workshop
1 = Very Low 2 = Low 3 = Moderate 4 = High 5 = Very High Mean SD
Prescribers (n = 55)
1. Satisfied with overall quality of educational 
activity
0% 0% 5.5% 36.4% 58.2% 4.53 0.60
2. Content of program was relevant to practice 0% 0% 22.0% 30.9% 47.3% 4.25 0.80
3. Program enhanced your knowledge 0% 3.6% 9.1% 45.5% 41.8% 4.25 0.78
4. As a result of participation, feel equipped to 
implement the strategies
0% 0% 16.4% 43.6% 40.0% 4.24 0.72
5. Time allotted for training was sufficient 0% 0% 21.8% 43.6% 34.6% 4.13 0.75
6. Feel that you need additional training to feel 
comfortable using the strategies
9.1% 36.4% 23.6% 20.0% 10.9% 2.87 1.17
7. Content of training was useful to you 0% 3.6% 12.7% 36.4% 47.3% 4.27 0.83
All others (n = 75)
1. Satisfied with overall quality of educational 
activity
0% 0% 10.7% 44.0% 45.3% 4.35 0.67
2. Content of program was relevant to practice 0% 0% 14.7% 44.0% 42.7% 4.27 0.70
3. Program enhanced your knowledge 0% 0% 16.0% 46.7% 37.3% 4.21 0.70
4. As a result of participation, feel equipped to 
implement the strategies
0% 0% 28.0% 45.3% 26.7% 3.97 0.74
5. Time allotted for training was sufficient 0% 0% 20.0% 53.3% 26.7% 4.07 0.68
6. Feel that you need additional training to feel 
comfortable using the strategies
16.0% 30.7% 17.3% 24.0% 12.0% 2.85 1.29
7. Content of training was useful to you 0% 6.7% 10.7% 48.0% 34.7% 4.11 0.85
Note:  Ratings provided by 130 workshop attendees (124 in-person and 6 prescribers online due to schedule incompatibility); 43/55 prescribers 
(78%) held M.D. or D.O. degrees; the remaining were nurse practitioners (10) or physician assistants (2); 50/75 staff (66%) held MSN, BSN, CMA, 
LPN, RN, or MA degrees; the remaining were other office staff.  
Supplement 1. Table 1. Practice demographics
Pediatrics Family Medicine
1 2 3 1 2 3
Patients 15,200 8,500 20,000 20,000 51,000 32,000
Providers 14 16 13 7 21 11
MD/DO 12 9 7 7 21 11
NP 1 6 6 0 0 0
PA 1 1 0 0 0 0
Clinical Staff 24 12 19 10 31 18
RN 19 2 13 1 8 3
MA 3 10 4 6 22 12
LPN 2 0 2 3 1 3
Additional Staff 13 5 12 7 26 21
Office 11 4 12 5 19 12
Behavioral health 2 0 0 0 0 0
Othera 0 1 0 2 7 9
Note: aOther staff included positions related to medical records (n=3), management (n=11), referrals/authorizations (n=2), radiology (n = 2), and 
lactation specialists (n=1). Data were provided by practice between March 27, 2019 and April 9, 2019 and are estimates of practice staffing and 
patient population at the time data collection occurred. 
Supplement 2.  Increased storage of stimulants in purse/backpack.
Post-hoc analyses were conducted to explore changes in stimulant storage location from 
Time 1 to Time 2. Participants were asked, “Where do you keep your stimulant medication?” 
and were provided the following response options: medicine cabinet, bathroom counter, other 
bathroom location, kitchen cabinet, kitchen counter, other kitchen location, dresser drawer, top 
of dresser, other bedroom location, purse/backpack, no set location, and other location. Due to 
variations in participants’ living situations, it is difficult to determine accessibility/safety of these 
locations (e.g. locked).  For example, if a participant lived alone in an apartment and kept their 
stimulant medication on top of a dresser, there might be little chance for others to access it. The 
opposite would be true if a participant lived in a shared dorm room.  One storage location option 
depended less on participants’ living situations: “purse/backpack.”  At Time 1, 34% (39/114) of 
participants said that they kept their stimulant medication in a purse/backpack, and at Time 2, 
42% (44/105) of participants did so. GEE analyses showed a significant increase from Time 1 to 
Time 2 in the percentages of participants who said they stored their stimulant medication in this 
location, Wald 2 = 3.967, p = 0.046, β(SE) = 0.44(0.22), Exp(β)=1.55.
